MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ENLV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enlivex Therapeutics (ENLV) Earnings Date & Reports

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

ENLV is expected to report earnings to fall 30.43% to -15 cents per share on May 29

Enlivex Therapeutics ENLV Stock Earnings Reports
Q1'25
Est.
$-0.16
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.03
Q1'24
Est.
$-0.25
The last earnings report on March 31 showed earnings per share of -23 cents, missing the estimate of -15 cents. With 23.50K shares outstanding, the current market capitalization sits at 21.94M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ENLV
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For ENLV
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com